We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals

15 hedge funds and large institutions have $1.02M invested in Armata Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1515 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

73% less capital invested

Capital invested by funds: $3.77M → $1.02M (-$2.76M)

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ARMP Hedge Fund Activity: Q4 2016 in Review

15 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2016, worth a combined $1.02M — down 73% from $3.77M a quarter earlier.

Fund positioning in ARMP was balanced in Q4 2016: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $886K. The largest seller was Third Security, exiting entirely with an estimated $2.41M sold.

  • 15 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $1.02M of Armata Pharmaceuticals stock for Q4 2016, down 73% quarter-over-quarter.
  • 4 funds opened new Armata Pharmaceuticals positions in Q4 2016 and 4 closed out, a net change of 0 holders.
  • The largest Armata Pharmaceuticals buyer in Q4 2016 was Sabby Management, an estimated $886K added.
  • The largest Armata Pharmaceuticals seller in Q4 2016 was Third Security, an estimated $2.41M sold.

Based on aggregated 13F filings for Q4 2016.